Skip to main content
. 2021 Apr 24;11(1):74–82. doi: 10.14283/jfa.2021.17

Table 3.

Participant characteristics (N=18)

Characteristic Mean (SD) or N (%)
Age (years) 71.5 (5.3)
Sex (female) 10 (56%)
Ethnicity Hispanic or Latino 9 (50%)
Not Hispanic or Latino 9 (50%)
T2D duration (years, SD) 14.4 (9.4)
T2D Treatment (%) Oral agents 12 (66%)
Insulin 3 (17%)
Combination of oral agents and insulin 3 (17%)
Frailty Characteristics at baseline (Yes, %) Frailty Characteristics at 6-months (Yes, %)
Slowness 4 (22%) Slowness 2 (11%)
Weakness 9 (50%) Weakness 5 (27%)
Weight loss 3 (17%) Weight loss 0
Exhaustion 9 (50%) Exhaustion 6 (33%)
Physical activity 4 (22%) Low physical activity 3 (17%)
Frailty status at baseline Frailty status at 6-months
Pre-Frail 13 (72%) Pre-Frail 9 (50%)
Frail 4 (22%) Frail 2 (11%)
Non-Frail 1 (6%) Non-Frail 7 (39%)